Stereotaxis sells four Odyssey systems

Stereotaxis has sold four Odyssey systems to the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin, Texas. One of the systems will manage the institute’s  Niobe Remote Magnetic Navigation electrophysiology (EP) lab and the other three will manage its non-Niobe EP labs.

Odyssey workstations standardize data integration for magnetic and standard interventional labs through a consolidated display of multiple systems. Odyssey Cinema synchronizes the data from multiple interventional lab systems that can be viewed live or from an archive of cases performed. According to the company, the Texas Cardiac Arrhythmia Institute will be able to utilize the Odyssey network to connect with specific facilities globally.

St. Louis-based Stereotaxis said this was the largest Odyssey order to date.
Michael Bassett,

Contributor

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.